BioSpace News Archive

Head And Neck Cancer Therapeutics Market Size Will Attain USD 3.80 BN By 2030

According to Nova one advisor, the global Head And Neck Cancer Therapeutics market was valued at USD 1.40 billion in 2021 and it is expected to hit around USD 3.80 billion by 2030 with a CAGR of 12.9% during the forecast period 2022 to 2030.

November 7, 2022
·
7 min read
Genetown

GreenLight Biosciences to Participate in Upcoming Investor Conferences in November 2022

GreenLight Biosciences announced that Dr. Andrey Zarur, CEO, and Susan Keefe, CFO will participate in two upcoming investor conferences in November.

November 7, 2022
·
2 min read
Poxel Announces Upcoming Participation at the Jefferies 2022 London Healthcare Conference

POXEL SA announced its participation at the Jefferies London Healthcare Conference, to be held in London from Tuesday, November 15 to Thursday, November 17, 2022.

November 7, 2022
·
2 min read
Business

Standard BioTools and Visiopharm Announce Partnership for the Development of Complete Image Analysis Solutions to be Packaged With Hyperion and Hyperion+ Imaging Systems

Standard BioTools Inc. and Visiopharm® announced a collaboration to pair the company’s Hyperion™ and Hyperion+™ Imaging Systems with Visiopharm Phenoplex™ analysis software for simplified image processing and enhanced spatial pathology insights, building on the success of a co-marketing agreement announced last year.

November 7, 2022
·
7 min read